Small Cap Equity Portfolio HALO Holdings History
Small Cap Equity Portfolio's Halozyme Therapeutics Inc Holding Summary
As of 2025-04-30, GLENMEDE FUND INC held 270,512.00 shares of Halozyme Therapeutics Inc(HALO), totaling $16.61 Mil. This investment constitutes 1.62% of their stock portfolio, and GLENMEDE FUND INC now holds 0.22% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2022Q1. And since then Small Cap Equity Portfolio has made 3 purchases of HALO, at an average price of $37.19, for a total of 470,854.00 shares. In addition, there have been 8 sales at an average price of $49.97 for 200,342.00 shares. Based on historical transaction data and HALO's current price of $57.81, Small Cap Equity Portfolio's estimated gain on his HALO holdings is $8.14 Mil, reflecting a 46.48% gain to date.
Small Cap Equity Portfolio HALO ($57.81) Holding Chart
Small Cap Equity Portfolio HALO ($57.81) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
